ENVELOPE GENE-DERIVED RECOMBINANT PEPTIDE IN THE SERODIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
- 12 July 1986
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 328 (8498), 111-112
- https://doi.org/10.1016/s0140-6736(86)91648-x
Abstract
No abstract availableFunding Information
- Austrian Science Fund
- Japan Foundation, Manila
This publication has 8 references indexed in Scilit:
- New Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )Science, 1986
- Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic PeptideBio/Technology, 1985
- Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope GeneScience, 1985
- Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS PatientsScience, 1985
- A glycopolypeptide (gp 100) is the main antigen detected by HTLV-III antiseraMedical Microbiology and Immunology, 1985
- Evidence for Exposure to HTLV-III in Uganda Before 1973Science, 1985
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984